37
Participants
Start Date
November 15, 2025
Primary Completion Date
October 15, 2028
Study Completion Date
October 15, 2028
Empowering Pregnant Women and People Receiving medications for opioid use disorder (EMPWR)
EMPWR is evidence-informed, behavioral intervention to address risk factors for fear of opioid withdrawal, craving, and stress, with an adjective mobile application among pregnant women receiving opioid agonist therapies. The goal of EMPWR is to promote medication retention and adherence.
Medication monitoring (control)
Participants will record the dose and time buprenorphine was taken for two months via REDCap daily diaries, which will be delivered via text.
RECRUITING
Medical University of South Carolina, Charleston
National Institute on Drug Abuse (NIDA)
NIH
Medical University of South Carolina
OTHER